Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Barth

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Breast Cancer Research and Treatment|February 19, 2013
A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissueMargit M McGowan, Burton L Eisenberg, Lionel D Lewis, et al.
Breast Cancer Research and Treatment|December 11, 2014
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancerJennifer R Bean, Sarah R Hosford, Lynn K Symonds, et al.
Urology Practice|June 10, 2023
Opioid Stewardship in Urology: Quality Improvement Summit 2018Gregory Auffenberg, Angela B Smith, Timothy D Averch, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yangMarc S Ernstoff, Todd S Crocenzi, John D Seigne, et al.
Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patientsThomas Schwaab, Adrian Schwarzer, Benita Wolf, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Clinical Chemistry|May 14, 2014
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutationsXiaoying Liu, Kabir Mody, Francine B de Abreu, et al.
Oncotarget|March 3, 2016
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesRobert J Allaway, Dawn A Fischer, Francine B de Abreu, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Breast Cancer Research and Treatment|February 19, 2013
A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissueMargit M McGowan, Burton L Eisenberg, Lionel D Lewis, et al.
Breast Cancer Research and Treatment|December 11, 2014
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancerJennifer R Bean, Sarah R Hosford, Lynn K Symonds, et al.
Urology Practice|June 10, 2023
Opioid Stewardship in Urology: Quality Improvement Summit 2018Gregory Auffenberg, Angela B Smith, Timothy D Averch, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yangMarc S Ernstoff, Todd S Crocenzi, John D Seigne, et al.
Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patientsThomas Schwaab, Adrian Schwarzer, Benita Wolf, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Clinical Chemistry|May 14, 2014
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutationsXiaoying Liu, Kabir Mody, Francine B de Abreu, et al.
Oncotarget|March 3, 2016
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesRobert J Allaway, Dawn A Fischer, Francine B de Abreu, et al.
Pageof 9